174
Views
2
CrossRef citations to date
0
Altmetric
Clinical Trial Report

Efficacy of the combined use of a mild foaming cleanser and moisturizer for the care of infant skin

, , , , , , & show all
Pages 393-401 | Published online: 03 Oct 2017

Figures & data

Table 1 Full ingredient list of the test materials

Table 2 Prevalence of each skin symptom at week 0 based on visual skin assessment by dermatologist (number of infants)

Figure 1 Evaluation of dryness, desquamation, erythema, and papules following the usage of the cleanser and moisturizer on the face.

Notes: The numeric values in the columns show the number of subjects. **p < 0.01 as a significant improvement from week 0 (W0) to week 4 (W4) by the Wilcoxon signed-rank test. (A) Lotion group (n=22), (B) cream group (n=23).
Figure 1 Evaluation of dryness, desquamation, erythema, and papules following the usage of the cleanser and moisturizer on the face.

Figure 2 Typical clinical features of facial skin in an 8-month-old female infant.

Notes: The infant had dryness (score 1), desquamation (score 3), erythema (score 3), and papules (score 1) at week 0, but improvements were observed at week 4: dryness (score 0), desquamation (score 1), erythema (score 1), and papules (score 0). (A) Week 0, (B) week 4.
Figure 2 Typical clinical features of facial skin in an 8-month-old female infant.

Figure 3 Evaluation of dryness, desquamation, erythema, and papules following the usage of the cleanser and moisturizer on the buttocks.

Notes: The numeric values in the columns show the number of subjects. *p < 0.05 as a significant improvement from week 0 (W0) to week 4 (W4) by the Wilcoxon signed-rank test. (A) Lotion group (n=25), (B) cream group (n=24).
Figure 3 Evaluation of dryness, desquamation, erythema, and papules following the usage of the cleanser and moisturizer on the buttocks.

Figure 4 Evaluation of dryness, desquamation, erythema, and papules following the usage of the cleanser and moisturizer on the flexor of the arms.

Notes: The numerical values in the columns show the number of subjects. **p < 0.01 as a significant improvement from week 0 (W0) to week 4 (W4) by the Wilcoxon signed-rank test. (A) Lotion group (n=25), (B) cream group (n=25).
Figure 4 Evaluation of dryness, desquamation, erythema, and papules following the usage of the cleanser and moisturizer on the flexor of the arms.

Figure 5 TEWL, pH and capacitance of the face, flexor of the arm, and buttock following the usage of the cleanser and moisturizer.

Notes: (A, B) TEWL. (C, D) pH. (E, F) Capacitance. (A, C, E) Lotion group: face (n=22); flexor of the arm (n=25) and buttock (n=25); (B, D, F) cream group: face (n=23); flexor of the arm (n=24), buttock (n=25). *p < 0.05 as a significant improvement from week 0 (W0) to week 4 (W4) by the Wilcoxon signed-rank test.
Abbreviation: TEWL, transepidermal water loss.
Figure 5 TEWL, pH and capacitance of the face, flexor of the arm, and buttock following the usage of the cleanser and moisturizer.

Table 3 Overall improvement rate and usefulness judged by dermatologist (number of infants)

Figure 6 Parental assessments following the usage of the cleanser and moisturizer.

Notes: (A) Overall evaluation of the materials: cleanser (n=50), lotion (n=25), cream (n=25). (B) Recognition of improvement in dry skin: lotion group (n=25), cream group (n=25).
Figure 6 Parental assessments following the usage of the cleanser and moisturizer.